| Name |
Edemid 40 mg/4 ml otopina za injekciju/infuziju |
| Marketing Authorisation Number |
HR-H-170236895 |
| Active Substance |
furosemidnatrij |
| Composition |
1 ampula s 4 mL otopine za injekciju/infuziju sadrži 40 mg furosemida (u obliku furosemidnatrija). 1 ml otopine za injekciju/infuziju sadrži 10 mg furosemida (u obliku furosemidnatrija). |
| Pharmaceutical Form |
Otopina za injekciju / infuziju |
| Manufacturer |
Lek Pharmaceuticals d.d., Ljubljana, Slovenija |
| Marketing Authorisation Holder |
Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date |
15.06.2021 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/17-02/668 |
| Registration Number |
381-12-01/38-21-11 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C03CA01 |
| Marketing status |
Not marketed |
| SmPC |
download |
| PL |
download |
